OTCMKTS:SKVI Skinvisible (SKVI) Stock Price, News & Analysis → Elon Musk: THIS will be bigger than Tesla (From Paradigm Press) (Ad) Free SKVI Stock Alerts $0.75 0.00 (0.00%) (As of 06/14/2024 ET) Add Compare Share Share Today's Range$0.75▼$0.7550-Day Range$0.06▼$0.7552-Week Range$0.06▼$0.75Volume1 shsAverage Volume5,931 shsMarket Capitalization$3.67 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Get Skinvisible alerts: Email Address Ad InvestorPlaceJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market…Click here for the details About SkinvisibleSkinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women's health, pain management, and other markets. The company's flagship product is Invisicare, a patented polymer delivery system technology that enhances the delivery of active ingredients for topically applied skin care products. It also develops and licenses prescription and over-the-counter products to pharmaceutical and consumer goods companies; assists pharmaceutical clients in the early development of the formulations; and provides solutions to pharmaceutical companies by reformulating their products coming off patent with a new Invisicare patent, and new product benefits and line extensions. The company was formerly known as Microbial Solutions, Inc. and changed its name to Skinvisible, Inc. in February 1999. Skinvisible, Inc. was incorporated in 1998 and is based in Las Vegas, Nevada.Read More SKVI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SKVI Stock News HeadlinesMay 29, 2024 | finanznachrichten.deSkinvisible, Inc.: Skinvisible Submits Innovative Obesity Patent for Advanced Transdermal TreatmentMay 29, 2024 | finance.yahoo.comSkinvisible Submits Innovative Obesity Patent for Advanced Transdermal TreatmentMay 15, 2024 | seekingalpha.comZHUD Zhuding International LimitedFebruary 14, 2024 | finanznachrichten.deSkinvisible, Inc.: Skinvisible Announces Significant Progress in Licensee's Clinical Trials for Invisicare Formulation Targeting Nethertons SyndromeFebruary 14, 2024 | finance.yahoo.comSkinvisible Announces Significant Progress in Licensee's Clinical Trials for Invisicare Formulation Targeting Nethertons SyndromeMarch 2, 2023 | finance.yahoo.comSkinvisible, Inc. (SKVI) Stock Historical Prices & Data - Yahoo FinanceSeptember 8, 2022 | reuters.comSKVI.PK - Skinvisible Inc | Stock Price & Latest News | ReutersJune 6, 2022 | finanznachrichten.deSkinvisible Inc: Skinvisible Announces First Invisicare Delivery Technology Product to Receive U.S. FDA Acceptance of Investigational New DrugSee More Headlines Receive SKVI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Skinvisible and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/16/2024Today6/16/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:SKVI CUSIPN/A CIK1085277 Webwww.skinvisible.com Phone(702) 433-7154Fax702-433-7192Employees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,380,000.00 Net Margins-5,790.00% Pretax Margin-5,785.00% Return on EquityN/A Return on Assets-663.94% Debt Debt-to-Equity RatioN/A Current Ratio0.01 Quick Ratio0.01 Sales & Book Value Annual Sales$20,000.00 Price / Sales183.38 Cash FlowN/A Price / Cash FlowN/A Book Value($1.99) per share Price / Book-0.38Miscellaneous Outstanding Shares4,890,000Free Float2,298,000Market Cap$3.67 million OptionableNot Optionable Beta-0.30 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Terry H. Howlett (Age 76)President, CEO, CFO, Principal Accounting Officer & Director Comp: $180kMs. Doreen McMorran (Age 62)Head of Business Development Key CompetitorsCeaproOTCMKTS:CRPOFVaxxinityNASDAQ:VAXXGuardion Health SciencesNASDAQ:GHSIRedHill BiopharmaNASDAQ:RDHLInhibitor TherapeuticsOTCMKTS:INTIView All Competitors SKVI Stock Analysis - Frequently Asked Questions How have SKVI shares performed in 2024? Skinvisible's stock was trading at $0.0838 on January 1st, 2024. Since then, SKVI stock has increased by 795.5% and is now trading at $0.75. View the best growth stocks for 2024 here. How were Skinvisible's earnings last quarter? Skinvisible, Inc. (OTCMKTS:SKVI) posted its earnings results on Tuesday, April, 16th. The company reported ($0.07) earnings per share (EPS) for the quarter. The firm earned $0.01 million during the quarter. What other stocks do shareholders of Skinvisible own? Based on aggregate information from My MarketBeat watchlists, some companies that other Skinvisible investors own include HEXO (HEXO), BTCS (BTCS), Bunker Hill Mining (BHLL), Blue Dolphin Energy (BDCO), American Power Group (APGI), Advanced Oxygen Technologies (AOXY), Aeolus Pharmaceuticals (AOLS), Akari Therapeutics (AKTX), Adicet Bio (ACET) and Aurora Cannabis (ACB). How do I buy shares of Skinvisible? Shares of SKVI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:SKVI) was last updated on 6/16/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredCatalyst Could Trigger 10,000% Crypto GainsAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealt...Crypto 101 Media | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredBitcoin’s Biggest Year Yet2024 is set to be a historic year for Bitcoin. It’s all thanks to three major catalysts that I reveal in my...Paradigm Press | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredTrump conviction scandal exposedIn this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Skinvisible, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Skinvisible With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.